Delivery Order SPE2DB22D2006-SPE2DB23FW3AU
- Not listed
- This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution in 120ml bottles to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,707.24 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,463.26 firm fixed-price delivery order is for the supply of Cetirizine HCL 1 mg/ml solution, 120 ml, to support military healthcare programs. The award has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles to the Defense Logistics Agency (DLA). The $3,054.98 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of July 6, 2023 and was awarded on July 5, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products to federal agencies,...
- This federal contract award is for the delivery of Cetirizine HCl 1 mg/ml solution in 120 ml bottles to the Defense Logistics Agency (DLA). The $1,275.60 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,189.78 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 9, 2023, with a completion date of August 10, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant...
- This federal contract award is for the delivery of Cetirizine HCL 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,168.23, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of January 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,278.93 for the supply of Cetirizine HCL 1 mg/ml solution. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a performance period that ends on December 28, 2022. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $23,781.84 and is a firm fixed price delivery order with a completion date of May 13, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, for the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles. The award, valued at $7,769.01, is a firm fixed-price delivery order with a completion date of May 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,037.47 firm fixed-price delivery order is for the supply of Cetirizine HCL 1 mg/ml solution, a generic antihistamine medication. The contract has an ultimate completion date of April 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FW3AUDelivery Order
This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $25,295.68 and an ultimate completion date of September 21, 2023. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.3k | 9/20/23 |